MedTrace Logo

Plasma Transfusion in Liver Transplantation

NCT00235183 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2014-02-17

No results posted yet for this study

Summary

The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation.

Conditions

  • Bleeding in Liver Transplantation

Interventions

OTHER

plasma

transfusion of more than 15 mL/Kg of plasma

Sponsors & Collaborators

  • Etablissement Français du Sang

    lead OTHER

Principal Investigators

  • Yves Ozier, MD, PhD · Hôpital Cochin, Paris, France

  • Emmanuel Samain, MD, PhD · hôpital Jean Minjoz, Besançon, France

  • Marie - Christine Gillon, MD · Hôpital Paul Brousse, Villejuif, France

  • Loïc Villalon, MD · Hôpital Pontchaillou

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2009-12-31
Completion
2010-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00235183 on ClinicalTrials.gov